FDA Drug · D-0850-2026

Dextrose Injection, USP, 70 %, 2000 mL bags, Rx Only, Baxter Healthcare Corporation Deerfield, IL, 60016, Made in USA, NDC 00338-0719-06

Class I · Ongoing

Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.

Affected lots / codes — check yours against thisLot #: Y495066, Exp. Date July 31, 2027

Recalling firm: Baxter Healthcare Corporation, Deerfield, IL
Classification: Class I (most serious — risk of serious harm)
Status: Ongoing
Quantity: 606 bags
Distribution: U.S. Nationwide.
Recall initiated: August 17, 2026
Classified: September 15, 2026
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0850-2026%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →